letrozole 2.5 mg

DRUG2 trials

Sponsors

University of Kansas, Capital Medical University

Conditions

Breast CancerBreast NeoplasmsNeoplasm Metastasis

Unknown Phase

An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg

CompletedNCT00291109

University of KansasBreast Cancer

Start: 2003-01-31End: 2005-07-31Target: 40Updated: 2008-09-16

Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients

CompletedNCT02583828

Capital Medical UniversityBreast Neoplasms, Neoplasm Metastasis

Start: 2015-06-30End: 2021-12-31Updated: 2024-02-07